CoChat

Human dendritic cells transfected with either RNA or DNA encoding influenza matrix protein M1 differ in their ability to stimulate cytotoxic T lymphocytes

Strobel, I, Berchtold, S, Götze, A, Schulze, U, Schuler, G, Steinkasserer, A · 2000 · Gene Therapy
Cited by 111

The DOI matches its Crossref record; 3 of the 3 references it cites were found in a registry or an index.

Overview

The claims and statistics of this paper haven’t been checked yet.

Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.

A few free checks a day · papers already verified open instantly · results are public

Integrity signals

Registry

Crossref · 10.1038/sj.gt.3301326

Cites

3 of 3 references verified0 citation errors · 0 not checkable

Statistics

Verification

Claims the paper makes

The claims and statistics of this paper haven’t been checked yet.

Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.

A few free checks a day · papers already verified open instantly · results are public

Claims other papers make about this one

Each is checked against this paper’s own text: does it say what the citing paper says it does?

Self-check

Percentages, sums and reported differences re-computed from the paper’s own numbers.

The self-check needs the paper’s full text.

Citations

Cites

Show all 3 references

Research works printed but not linked: 41

  1. Romero P et al. Ex vivo staining of metastatic lymph nodes by class I major histocompatibility complex tetramers reveals high numbers of antigen-experienced tumor-specific cytolytic T lymphocytes J Exp Med 1998 188: 1641–1650 · DOI · Paper page
  2. Speiser DE et al. In vivo expression of natural killer cell inhibitory receptors by human melanoma-specific cytolytic T lymphocytes J Exp Med 1999 190: 775–782 · DOI · Paper page
  3. Lee PP et al. Characterization of circulating T cells specific for tumor-associated antigens in melanoma patients Nature Med 1999 5: 677–685 · DOI · Paper page
  4. Doyle A et al. Markedly decreased expression of class I histocompatibility antigens, protein, and mRNA in human small-cell lung cancer J Exp Med 1985 161: 1135–1151 · DOI · Paper page
  5. Banchereau J, Steinman RM . Dendritic cells and the control of immunity Nature 1998 392: 245–252 · DOI · Paper page
  6. Steinman RM . Dendritic cells. In: Paul WE (ed) Fundamental Immunology Lippincott-Raven: Philadelphia 1999 pp 547–573
  7. Schuler G, Steinman RM . Dendritic cells as adjuvants for immune-mediated resistance to tumors J Exp Med 1997 186: 1183–1187 · DOI · Paper page
  8. Mayordomo JI et al. Bone marrow-derived dendritic cells pulsed with synthetic tumor peptides elicit protective and therapeutic antitumor immunity Nature Med 1995 1: 1297–1302 · DOI · Paper page
  9. Murphy G et al. Phase I clinical trial: T cell therapy for prostate cancer using autologous dendritic cells pulsed with HLA-A0201-specific peptides from prostate-specific membrane antigen Prostate 1996 29: 371–380 · DOI · Paper page
  10. Marchand M et al. Tumor regressions observed in patients with metastatic melanoma treated with an antigenic peptide encoded by gene MAGe-3 and presented by HLA-A1 Int J Cancer 1999 80: 219–230 · DOI · Paper page
  11. Thurner B et al. Intracutaneous vaccination with Mage-3.A1 peptide-pulsed mature monocyte-derived dendritic cells expands specific cytotoxic T cells and induces regression of some metastases in advanced stage IV melanoma J Exp Med 1999 190: 1669–1678 · DOI · Paper page
  12. Dhodapkar MV et al. Rapid generation of broad T cell immunity in humans after a single injection of mature dendritic cells J Clin Invest 1999 104: 173–180 · DOI · Paper page
  13. van Elsas A et al. Peptide-pulsed dendritic cells induce tumoricidal cytotoxic T lymphocytes from healthy donors against stably HLA-A*0201-binding peptides from the Melan-A/MART-1 self antigen Eur J Immunol 1996 26: 1683–1689 · doi:10.1002/eji.1830260803
  14. Choudhury A et al. Use of leukemic dendritic cells for the generation of antileukemic cellular cytotoxicity against Philadelphia chromosome-positive chronic myelogenous leukemia Blood 1997 89: 1133–1142 · DOI · Paper page
  15. Porgador A, Snyder D, Gilboa E . Induction of antitumor immunity using bone marrow-generated dendritic cells J Immunol 1996 156: 2918–2926 · DOI · Paper page
  16. Gabrilovich DI, Ciernik IF, Carbone DP . Dendritic cells in antitumor immune responses. I. Defective antigen presentation in tumor-bearing hosts Cell Immunol 1996 170: 101–110 · DOI · Paper page
  17. Boon T, van der Bruggen P . Human tumor antigens recognized by T lymphocytes J Exp Med 1996 183: 725–729 · DOI · Paper page
  18. Reeves ME et al. Retroviral transduction of human dendritic cells with a tumor-associated antigen gene Cancer Res 1996 56: 5672–5677
  19. Szabolcs P et al. Retrovirally transduced human dendritic cells express a normal phenotype and potent T-cell stimulatory capacity Blood 1997 90: 2160–2167 · DOI
  20. Verhasselt B et al. Retrovirally transduced CD34++ human cord blood cells generate T cells expressing high levels of the retroviral encoded green fluorescent protein marker in vitro Blood 1998 91: 431–440 · doi:10.1182/blood.v91.2.431
  21. Song W et al. Dendritic cells genetically modified with an adenovirus vector encoding the cDNA for a model antigen induce protective and therapeutic antitumor immunity J Exp Med 1997 186: 1247–1256 · DOI · Paper page
  22. Wan Y et al. Dendritic cells transduced with an adenoviral vector encoding a model tumor-associated antigen for tumor vaccination Hum Gene Ther 1997 8: 1355–1363 · DOI · Paper page
  23. Arthur JF et al. A comparison of gene transfer methods in human dendritic cells Cancer Gene Ther 1997 4: 17–25
  24. Dietz AB, Vuk-Pavlovic S . High efficiency adenovirus-mediated gene transfer to human dendritic cells Blood 1998 91: 392–398 · DOI · Paper page
  25. Zhong L, Granelli-Piperno A, Choi Y, Steinman RM . Recombinant adenovirus is an efficient and non-perturbing genetic vector for human dendritic cells Eur J Immunol 1999 29: 964–972 · DOI · Paper page
  26. Di Nicola M et al. Gene transfer into human dendritic antigen-presenting cells by vaccinia virus and adenovirus vectors Cancer Gene Ther 1998 5: 350–356
  27. Engelmayer J et al. Vaccinia virus inhibits the maturation of human dendritic cells: a novel mechanism of immune evasion J Immunol 1999 163: 6762–6768 · DOI · Paper page
  28. Drillen R, Spehner D, Bohbot A, Hanau D . Vaccinia virus-related events and phenotypic changes after infection of dendritic cells derived from human monocytes Virology 2000 268: 471–481 · DOI
  29. Tüting T et al. Autologous human monocyte-derived dendritic cells genetically modified to express melanoma antigens elicit primary cytotoxic T cell responses in vitro: enhancement by cotransfection of genes encoding the Th1-biasing cytokines IL-12 and IFN-a J Immunol 1998 160: 1139–1147 · DOI
  30. Alijagic S et al. Dendritic cells generated from peripheral blood transfected with human tyrosinase induce specific T cell activation Eur J Immunol 1995 25: 3100–3107 · DOI
  31. Van Tendeloo VF et al. Nonviral transfection of distinct types of human dendritic cells: high-efficiency gene transfer by electroporation into hematopoietic progenitor-, but not monocyte-derived dendritic cells Gene Therapy 1998 5: 700–707 · doi:10.1038/sj.gt.3300626
  32. Ashley DM et al. Bone marrow-generated dendritic cells pulsed with tumor extracts or tumor RNA induce antitumor immunity against central nervous system tumors J Exp Med 1997 186: 1177–1182 · DOI · Paper page
  33. Nair SK et al. Induction of primary carcinoembryonic antigen (CEA)-specific cytotoxic T lymphocytes in vitro using human dendritic cells transfected with RNA Nat Biotech 1998 16: 364–369 · DOI · Paper page
  34. Nair SK et al. Induction of carcinoembryonic antigen (CEA)-specific cytotoxic T-lymphocyte responses in vitro using autologous dendritic cells loaded with CEA peptide or CEA RNA in patients with metastatic malignancies expressing CEA Int J Cancer 1999 82: 121–124 · DOI · Paper page
  35. Boczkowski D et al. Induction of tumor immunity and cytotoxic T lymphocyte responses using dendritic cells transfected with messenger RNA amplified from tumor cells Cancer Res 2000 60: 1028–1034
  36. Hoerr I, Obst R, Rammensee HG, Jung G . In vivo application of RNA leads to induction of specific cytotoxic T lymphocytes and antibodies Eur J Immunol 2000 30: 1–7 · doi:10.1002/1521-4141(200001)30:1<1::aid-immu1>3.0.co;2-#
  37. Heiser A et al. Human dendritic cells transfected with RNA encoding prostate-specific antigen stimulate prostate-specific CTLresponses in vitro J Immunol 2000 164: 5508–5514 · DOI · Paper page
  38. Jonuleit H et al. Pro-inflammatory cytokines and prostaglandins induce maturation of potent immunostimulatory dendritic cells under fetal calf serum-free conditions Eur J Immunol 1997 27: 3135–3142 · DOI · Paper page
  39. Dunbar PR et al. Direct isolation, phenotyping and cloning of low-frequency antigen-specific cytotoxic T lymphocytes from peripheral blood Curr Biol 1998 8: 413–416 · DOI · Paper page
  40. Herr W et al. The use of computer-assisted video image analysis for the quantification of CD8+ T lymphocytes producing tumor necrosis factor alpha spots in response to peptide antigens J Immunol Methods 1997 203: 141–152 · DOI
  41. Strobel I et al. Efficient expression of the tumor-associated antigen MAGE-3 in human dendritic cells using an avian influenza virus vector Hum Gene Ther 2000 (in press · DOI

Cited by

See all 111

Metadata

Authors
Strobel, I., Berchtold, S., Götze, A., Schulze, U., Schuler, G., & Steinkasserer, A.
Venue
Gene Therapy
Published
2000-12-01
Volume
7
Issue
23
Pages
2028-2035
ISSN
  • 0969-7128
  • 1476-5462
Cited by
111
References
3
Language
en
Licence

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review

How to cite

Cite CoChat for the checks on this page, and the paper for its own findings.

This page
CoChat. (2026). Citation check: Human dendritic cells transfected with either RNA or DNA encoding influenza matrix protein M1 differ in their ability to stimulate cytotoxic T lymphocytes. https://app.cochat.ai/papers/10.1038/sj.gt.3301326
The paper
Strobel, I., Berchtold, S., Götze, A., Schulze, U., Schuler, G., & Steinkasserer, A. (2000). Human dendritic cells transfected with either RNA or DNA encoding influenza matrix protein M1 differ in their ability to stimulate cytotoxic T lymphocytes. Gene Therapy. https://doi.org/10.1038/sj.gt.3301326

Data sources

Bibliographic data: Semantic Scholar, OpenAlex, Crossref.

Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).

Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.